WeGovy for Medical Weight Loss in Miami, FL

Wegovy is a type of medication that has been FDA-approved for weight loss due to its efficacy in reducing the appetite and supporting the metabolism of the patient. The primary ingredient of Wegovy is semaglutide, which was previously only FDA-approved for those with type 2 diabetes but was regularly prescribed by physicians for off-label use as a weight loss medication. To ensure that semaglutide was safe and effective for weight loss, Wegovy was created with weight loss in mind when determining the quantities and dosing, making it very safe and effective when used as part of a medical weight loss program. To get a prescription for Wegovy for weight loss, patients will need to schedule a consultation with a qualified physician to assess their overall health and weight to determine if they will be eligible for Wegovy. 

The amount of weight that you will be able to lose within a month while taking Wegovy depends on multiple factors including how your body responds to the medication (as this can impact how quickly the dose can be increased, making it more effective), how long you have already been taking the medication, any pre-existing health conditions, as well as how closely you have been following the other components of the medical weight loss program. 

Once the full dose has been reached, patients can expect to lose around 1 to 2 pounds per week if they can also maintain a calorie-deficient diet and exercise schedule. It is also common for patients to lose a little bit more weight within the first month, with an average of 5% total body weight being lost within that initial month, followed by around 8% two months after starting treatment. For a more accurate weight loss estimate, patients are encouraged to discuss goals and expectations with their supervision physician during their initial consultation as there are so many factors to take into account. 

Wegovy can only be accessed through a prescription provided by a licensed healthcare provider, so any patient who is looking to start Wegovy for weight loss will need to be deemed a good fit for the medication during a consultation. Since it is a weight loss medication, patients will need to be at an increased risk of weight-related health conditions or complications due to their weight, meaning they will likely already be considered obese or overweight with pre-existing weight-related health conditions.
 
Wegovy will also only be provided to patients who are partaking in a medical weight loss program as patients need to aid the process by limiting their calorie intake and staying active. However, not everyone who falls into these categories will be prescribed Wegovy as there are some contraindications or health risks that should be considered. For example, Wegovy will likely not be recommended for patients who have a family history of medullary thyroid carcinoma, have a history of multiple endocrine neoplasia syndrome type 2, have a health condition that affects the health of their pancreas or kidneys, or are currently breastfeeding or pregnant. 

While it will be up to the judgment of a health care provider to determine if a patient is eligible for Wegovy and will find the treatment to be safe and effective, there is a BMI requirement that will be considered that helps to determine if Wegovy will work to reduce the health risks associated with weight. To receive a prescription, patients will need to either have a BMI of 30 or higher, classifying them as obese or will need to have a BMI of 27 or higher to classify them as overweight, alongside a weight-related health condition. Our clinics are located at two locations in Coral Gables, FL, and Pinecrest, FL. You can contact us or book an online appointment for both locations. We serve clients from Coral Gables FL, Miami FL, Pinecrest FL, South Miami FL, Coconut Grove FL, Brickell FL, Kendall FL, Richmond Heights FL, and Westchester FL.